Alkermes (ALKS) Revenue (2010 - 2026)
Alkermes (ALKS) reported Revenue of $39.5 million for Q1 2026, down 87.11% year-over-year from $306.5 million in Q1 2025, and down 89.73% quarter-over-quarter from $384.5 million in Q4 2025.
Alkermes (ALKS) Revenue (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Revenue data on file, last reported at $39.5 million in Q1 2026.
- Revenue for Q1 2026 came in at $39.5 million, down 87.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 20.14% YoY), and the FY2025 annual result was $1.5 billion, down 5.25% from the prior year.
- Revenue fell to $39.5 million in Q1 2026 per ALKS's latest filing, from $384.5 million in the prior quarter.
- Over five years, Revenue peaked at $617.4 million in Q2 2023 and troughed at $3.2 million in Q2 2022.
- A 5-year average of $313.3 million and a median of $377.5 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue plunged 98.95% in 2022, then jumped 19193.66% in 2023.
- A 5-year view of Revenue shows it stood at $304.7 million in 2022, then increased by 23.89% to $377.5 million in 2023, then climbed by 13.91% to $430.0 million in 2024, then declined by 10.57% to $384.5 million in 2025, then sank by 89.73% to $39.5 million in 2026.
- Business Quant data shows ALKS's Revenue at $39.5 million in Q1 2026, $384.5 million in Q4 2025, and $394.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 132.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.50 Mn |
| Dec 31, 2025 | 384.55 Mn |
| Sep 30, 2025 | 394.19 Mn |
| Jun 30, 2025 | 390.66 Mn |
| Mar 31, 2025 | 306.51 Mn |
| Dec 31, 2024 | 429.99 Mn |
| Sep 30, 2024 | 378.14 Mn |
| Jun 30, 2024 | 399.13 Mn |
| Mar 31, 2024 | 350.37 Mn |
| Dec 31, 2023 | 377.48 Mn |
| Sep 30, 2023 | 380.94 Mn |
| Jun 30, 2023 | 617.40 Mn |
| Mar 31, 2023 | 287.60 Mn |
| Dec 31, 2022 | 304.67 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 3.20 Mn |
| Mar 31, 2022 | 278.55 Mn |
| Dec 31, 2021 | 324.46 Mn |
| Sep 30, 2021 | 294.14 Mn |
| Jun 30, 2021 | 303.72 Mn |